AN1

0.00%

0.8¢ anagenics limited

Roquefort/Lyramid postings, page-141

First 141 Last

Share
Profile

Follow
phillit

388 Posts.

62

19/09/22

09:39

Post #: 63766590
Share

Originally posted by phillit: ↑

What I find interesting from an Anagenics point of view is in some recent announcements by Roquefort, and also in its September 13 Prospectus.

Recently, Roquefort announced that the well known cancer tumour enhancement effect, and the cancer medication inhibitory effect, of the complete Midkine protein molecule could also be achieved by a "truncated" Midkine molecule. That is, by part of the Midkine molecule with some bits chopped off. Roquefort has also announced that it has recently applied for Patents in Australia and the UK following the research that discovered this fact ( if it is a fact).

My thinking is....What if the purpose of the purchase of Oncogeni and its Laboratory facilities was to discover if that part, or indeed other parts, of the Midkine molecule, and even other chemical groups, could be manufactured, and then,if clinically effective, might they be considered "new" and not Midkine at all? Remember their Patent applications. What are they all about? Maybe some of the bits chopped off are effective. That is for their Lab research.

Would this activity be bad? Well,it could be very good for the sick as far as cancer and other diseases are concerned if it is successful in the years ahead. No guarantee of ultimate success, naturally.

Now to the Roquefort Prospectus. Look at pages 4 and 5. Study the principle activities as at the now time of the September 13 Prospectus, and then the proposed principle activities after the September 16 Oncogeni purchase. Midkine mentioned now, Midkine not mentioned then.Take in the general tone. Also,Roquefort advises in the Prospectus that it now has three subsidiaries, of which Lyramid is just one.

Then consider the new Board. Where is Midkine mentioned? Dr Robertson is not on the Board, but is mentioned in the Prospectus as the Lyramid employee. Maria Halasz is not mentioned at all, but I am sure would be if still giving "strategic advice". She was important enough to be mentioned before. Why not now?

Expand

Originally posted by Pharmargeddon: ↑

You been celebrating racehorse winnings again??

https://www.roquefortplc.com/about/board-senior-management/Guess who is at number four in the new revamped listing of directors and senior management.

Expand

Originally posted by Pharmargeddon: ↑

Dr Robertson is not a director.
He is the Chief Scientific Officer in Australia.
As set out in the current up to date ROQ website.
As Reginal et al from Ocogenic are on there - they could only have arrived on the website at the conclusion of the acquisition process.

Stop trying to find secret squirrels.

Expand

You now agree with my statement. At last some progress. Dr. Robertson is not a Director. And yet you still want to carry on.This is not Kindergarten, Grow up. Roquefort announcements require analysis.

I don't have the time to waste with you and your nit picking.But I will not stop analysing Company announcements when required.

Good luck with your dreams of "unlimited revenue" to Anagenics.

AN1 Price at posting: 3.8¢ Sentiment: Hold Disclosure: Held
2 Upvote

2 Great analysis

Reply

There are more pages in this discussion • 46 more messages in this thread...

First 141 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.691M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	148634	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	220199	1

View Market Depth

No.	Vol.	Price($)
2	148634	0.008
3	788022	0.007
2	342999	0.006
2	400000	0.005
1	125000	0.004

Price($)	Vol.	No.
0.009	220199	1
0.010	150000	2
0.012	40100	1
0.014	438077	1
0.019	260000	1

Last trade - 16.12pm 09/05/2024 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

Roquefort/Lyramid postings, page-141

Featured News

UNITH's digital humans expand into Amazon; Facebook

Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan

CBA profits fall 3% in March quarter but funding portfolio is flourishing

Recce breathes better on positive lung infection drug pilot test results

Raiden opens door to private Mallina in win-win Arrow Gold divestment

Buyers (Bids)

Sellers (Offers)

Featured News

Roquefort/Lyramid postings, page-141

Featured News

Top Stories

UNITH's digital humans expand into Amazon; Facebook

Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan

CBA profits fall 3% in March quarter but funding portfolio is flourishing

Recce breathes better on positive lung infection drug pilot test results

Raiden opens door to private Mallina in win-win Arrow Gold divestment

Buyers (Bids)

Sellers (Offers)

Featured News